Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
UBS
Boehringer Ingelheim
Cerilliant
McKinsey
Daiichi Sankyo
Baxter
US Department of Justice
Accenture

Generated: June 24, 2018

DrugPatentWatch Database Preview

FUROXONE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Furoxone, and what generic alternatives are available?

Furoxone is a drug marketed by Shire and is included in two NDAs.

The generic ingredient in FUROXONE is furazolidone. There are three drug master file entries for this compound. Additional details are available on the furazolidone profile page.
Summary for FUROXONE
Drug patent expirations by year for FUROXONE
Synonyms for FUROXONE
2-Furanmethanimine, 5-nitro-N-(2-oxo-3-oxazolidinyl)-
2-Oxazolidinone, 3-(((5-nitro-2-furanyl)methylene)amino)-
2-Oxazolidinone, 3-((5-nitrofurfurylidene)amino)-
2-Oxazolidinone, 3-((5-nitrofurfurylidine)amino)-
2-Oxazolidinone, 3-[(5-nitrofurfurylidene)amino]-
2-Oxazolidinone, 3-[(5-nitrofurfurylidine)amino]-
2-Oxazolidinone, 3-[[(5-nitro-2-furanyl)methylene]amino]-
3-(((5-Nitro-2-furanyl)methylene)amino)-2-oxazolidinone
3-((5-Nitrofurfurylidene)amino)-2-oxazolidinone
3-((5-Nitrofurfurylidene)amino)-2-oxazolidone
3-((5-Nitrofurfurylidine)amino)-2-Oxazolidinone
3-((5-Nitrofurylidene)amino)-2-oxazolidone
3-([(5-Nitro-2-furyl)methylidene]amino)-1,3-oxazolidin-2-one #
3-(5-Nitro-furfurylideneamino)-oxazolidin-2-one
3-(5-Nitrofurfurylideneamino)-2-oxazolidinone
3-(5-nitrofurfurylideneamino)oxazolidin-2-one
3-(5'-Nitrofurfuralamino)-2-oxazolidone
3-[(1E)-2-(5-nitro(2-furyl))-1-azavinyl]-1,3-oxazolidin-2-one
3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone
3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone
3-[(5-Nitrofurfurylidine)amino]-2-Oxazolidinone
3-[(5-Nitrofurylidene)amino]-2-oxazolidone
3-[(E)-(5-nitro-2-furanyl)methylideneamino]-2-oxazolidinone
3-[(E)-(5-nitro-2-furyl)methyleneamino]oxazolidin-2-one
3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
3-[[(5-Nitro-2-furanyl)methylene]-amino]-2-oxazolidinone
3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone
3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone, 9CI
3-{[(1E)-(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one
3-{[(5-Nitro-2-furanyl)methylene]amino}-2-oxazolidinone
3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one
3-{[(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one
3-{[(E)-(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one
5-Nitro-N-(2-oxo-3-oxazolidinyl)-2-furanmethanimine
67-45-8
A835757
AB00052000_03
AB00443658
AB1009283
AC-11695
AC1NT43A
AI3-50103
AKOS001678302
AN-7001
BIDD:GT0182
Bifuron
Bio-0354
BPBio1_000743
BRD-K10647544-001-02-0
BRD-K11756522-001-03-2
BSPBio_000675
BSPBio_002052
C07999
CAS-67-45-8
CCG-40233
CCRIS 1540
CHEBI:5195
CHEMBL1103
component of Topazone
component of Tricofuron
Corizium
Coryzium
CS-4897
D00830
D03CUF
Dependal-M (TN)
Diafuron
DSSTox_CID_21997
DSSTox_GSID_41997
DSSTox_RID_79899
DTXSID4041997
EINECS 200-653-3
Enterotoxon
F-8900
Fiurox aerosol powder
Furall
Furaxon
Furaxone
Furazol
Furazolidine
furazolidinone
Furazolidon
Furazolidona
Furazolidona [INN-Spanish]
furazolidone
Furazolidone (USP/INN)
Furazolidone [INN:BAN]
Furazolidone, Antibiotic for Culture Media Use Only
Furazolidone, United States Pharmacopeia (USP) Reference Standard
Furazolidone, Vetec(TM) reagent grade
Furazolidone, VETRANAL(TM), analytical standard
Furazolidonum
Furazolidonum [INN-Latin]
Furazolum
Furazon
Furidon
Furovag
Furox
Furox Aerosol Powder (Veterinary)
Furoxal
Furoxane
Furoxon
Furoxone (TN)
Furoxone Liquid
Furoxone Swine Mix
Furozolidine
FZL
GA1580
Giardil
Giarlam
H863
HMS1920O22
HMS2091H03
HMS500E07
HSDB 7036
HY-B1336
I05-0078
IDI1_000085
InChI=1/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5
LS-100676
Medaron
MFCD00010550
MLS000069727
MLS001304180
MolPort-000-836-892
N-(5-Nitro-2-furfurylidene)-3-amino-2-oxazolidone
N-(5-Nitro-2-furfurylidene)-3-aminooxazolidine-2-one
NCGC00095304-01
NCGC00095304-02
NCGC00095304-03
NCGC00095304-04
NCGC00095304-05
NCGC00188974-01
NE48875
Neftin
NF 180
NF 180 custom mix ten
NF-180
Nicolen
Nifulidone
Nifuran
Nifurazolidone
Nifurazolidonum
Nitrofurazolidone
Nitrofurazolidonum
Nitrofuroxon
NSC 6469
NSC-6469
NSC-757038
NSC6469
NSC757038
Opera_ID_256
Optazol
Ortazol
Pharmakon1600-01500309
PLHJDBGFXBMTGZ-WEVVVXLNSA-N
Prestwick2_000808
Prestwick3_000808
Puradin
Roptazol
RP27582
s4528
SBB057396
SBI-0051388.P003
SC-12651
SCHEMBL64996
Sclaventerol
SMR000058228
SPECTRUM1500309
Spectrum5_000742
SR-05000001632
SR-05000001632-1
ST024756
STK388219
Tikofuran
Topazone
Tox21_111502
Tox21_111502_1
TR-022655
Trichofuron
Tricofuron
Tricoron
Trifurox
Usaf ea-1
Viofuragyn
WLN: T5OJ BNW E1UN- AT5NVOTJ
ZINC7997571

US Patents and Regulatory Information for FUROXONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire FUROXONE furazolidone SUSPENSION;ORAL 011323-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Shire FUROXONE furazolidone TABLET;ORAL 011270-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Baxter
Queensland Health
Boehringer Ingelheim
Mallinckrodt
Fuji
Merck
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.